NovaBay Pharmaceuticals (NBY) Stock Chart & Stock Price History $0.61 +0.02 (+3.45%) As of 03:12 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NovaBay Pharmaceuticals Stock Price Performance The NovaBay Pharmaceuticals (NBY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 11.64%, with a year-to-date return of 2.16%. In the past month, the stock has decreased 2.38%, reflecting recent market activity. As of the latest close, NovaBay Pharmaceuticals traded at $0.59 with a market cap of $3.45 million and volume of 30,504 shares. Receive NBY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.97%1 Month Performance-2.38%3 Month Performance+4.67%Year-To-Date Performance+2.16%1 Year Performance+11.64% NBY Stock Chart for Monday, August, 4, 2025 NBY Chart by TradingView NovaBay Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.58$0.59+2.15%$0.62$0.5730,504 shs$3.45 million07/31/2025$0.62$0.58-6.29%$0.62$0.5724,320 shs$3.38 million07/30/2025$0.63$0.62-1.90%$0.65$0.6027,192 shs$3.61 million07/29/2025$0.64$0.63-1.80%$0.65$0.6327,252 shs$3.68 million07/28/2025$0.67$0.64-4.28%$0.67$0.6427,473 shs$3.74 million07/25/2025$0.65$0.67+3.24%$0.69$0.65116,930 shs$3.91 million07/24/2025$0.66$0.65-0.64%$0.69$0.6440,821 shs$3.79 million07/23/2025$0.64$0.66+2.25%$0.66$0.636,895 shs$3.81 million07/22/2025$0.65$0.64-1.75%$0.68$0.648,923 shs$3.73 million07/21/2025$0.66$0.65-1.58%$0.66$0.6419,554 shs$3.80 million Get the Latest News and Ratings for NBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.65$0.66+2.00%$0.70$0.6515,680 shs$3.86 million07/17/2025$0.65$0.65+0.65%$0.69$0.6534,790 shs$3.78 million07/16/2025$0.67$0.65-3.61%$0.67$0.6222,579 shs$3.76 million07/15/2025$0.69$0.67-2.90%$0.69$0.6721,636 shs$3.90 million07/14/2025$0.69$0.69-0.29%$0.75$0.62195,982 shs$4.01 million07/11/2025$0.65$0.69+6.51%$0.70$0.6190,990 shs$4.03 million07/10/2025$0.65$0.65+0.05%$0.65$0.6113,186 shs$3.78 million07/09/2025$0.66$0.65-1.96%$0.69$0.6041,627 shs$3.78 million07/08/2025$0.66$0.66-0.08%$0.69$0.6337,222 shs$3.85 million07/07/2025$0.63$0.66+5.39%$0.70$0.6360,831 shs$3.86 million07/04/2025$0.63$0.63$0.64$0.608,792 shs$3.66 million07/03/2025$0.63$0.63+0.62%$0.64$0.608,792 shs$3.66 million Related Companies NERV Stock Price Chart ALVR Stock Price Chart PRPH Stock Price Chart EQ Stock Price Chart FLGC Stock Price Chart LPTX Stock Price Chart NXTC Stock Price Chart CARM Stock Price Chart BFRG Stock Price Chart TXMD Stock Price Chart Receive NBY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NBY) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
